Indeed, in murine tumor models of CAC and especially in breast cancer upon standard-of-care chemotherapy, S1PR4 ablation resulted in significantly reduced tumor growth through enhanced CD8+ T cell proliferation. The gene discussed is CD8A; the disease is breast cancer.